IP Group PLC is an early-stage investor and business builder focused on science and technology-based companies. The group identifies, backs, and grows businesses across three main thematic areas: HealthTech, DeepTech, and CleanTech. Its portfolio includes companies such as Oxford Nanopore Technologies, Hinge Health, Ceres Power, and Matter Machine. IP Group operates through subsidiaries including Parkwalk, which manages EIS funds, and IP Group Australia, which replicates the investment model in Australasia. The company maintains partnerships with research institutions including the University of Oxford, the University of Cambridge, Imperial College London, and the Group of Eight universities in Australia. It also manages the Northern Universities Venture Fund in partnership with Northern Gritstone. Founded in 2001, the group has a history of acquiring entities such as Fusion IP, Top Technology, Techtran, and Touchstone Innovations to expand its capabilities in IP commercialisation and early-stage investment.

Summarised from the company's own disclosures, fiscal year ended Dec 2021

Industry Asset Management Homepage ipgroupplc.com
Sector Financial Services IR page ipgroupplc.com/investor-relations
Tags
early-stage investment, university spin-outs, healthtech, deeptech, cleantech, ip commercialisation, eis fund management, venture capital, business building, Parkwalk, IP Group Australia, Oxford Nanopore Technologies, Hinge Health, Ceres Power, Matter Machine, Featurespace, Modern Biosciences, Istesso, Fusion IP, Top Technology, Techtran, Touchstone Innovations, Northern Gritstone, Northern Universities Venture Fund
Press page —

Metrics

Valuation  
Market cap £ 600.204M
Market cap (USD) $ 798.688M
P/E 9.38
PEG —
P/BV 0.62
P/S 1.18
P/OCF -30.78
P/FCF -30.62
Dividend yield —
Turnover / mcap —
Returns  
ROE 6.9%
ROI 7.0%
ROIC 6.4%
Profit margin —
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y —
Revenue up 5y —
Earnings growth 3y (net profit CAGR) —
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock Yes
Diluting (TTM) No
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 0
Quality score 46.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2009
Revenue — — — — 508.9M 234.2M — — — — — — — 2.3M 2.1M —
Net profit 66.9M -207M -174.4M -344.5M 449.3M 185.4M -78.9M -293.8M 53.4M -14.8M 75.1M 9.5M 72.6M 40.7M — —
Free cash flow -19.6M -25.1M -17.9M -23.8M 9.8M -27.5M — — — — — — — — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2009
Share price 0.35 0.48 0.59 0.59 1.17 — — — — — — — — — — —
Price performance 12m -0.26 -0.2 0.01 -0.5 — — — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (GBP) — 3.6M 6.9M 8.8M 8.2M 6.3M 3.3M
↳ YoY growth +91.7% +27.5% -6.8% -23.2% -47.6%
↳ 5y CAGR -1.7%
Borrowings, current (GBP) — — 15.4M 6.3M 6.3M 6.3M 120M
Borrowings, non-current (GBP) — — 36.4M 75.1M 129M 123M 0.00
Cash and deposits (GBP) 122M 128M 106M 88.7M 101M 116M 16.5M
Net debt (borrowings + leases - cash) (GBP) — — -53.9M -7.3M 34.3M 13.5M 103M
Cash flow detail
Operating cash flow (GBP) — -27.5M 10M -23.5M -17.9M -25.1M -19.5M
Purchases of property, plant and equipment (GBP) — 0.00 -200,000 -300,000 0.00 0.00 -100,000
Change in receivables (cash effect) (GBP) — 2.1M -3M -500,000 1.3M -700,000 -1.6M
Change in payables (cash effect) (GBP) — -14.3M 8.8M -2.8M -300,000 -7.3M -700,000
Dividends paid (cash effect) (GBP) — 0.00 -15M -12.3M -13M 0.00 —
Share buybacks (cash effect) (GBP) — 0.00 -27.2M -8M -100,000 -29.6M -45.7M
Interest paid (cash effect) (GBP) — -1.6M -1.5M 0.00 -5.5M -6.8M -6.4M
Share-based compensation (GBP) — 2.9M 2.6M 2.9M 2.6M 1.9M 2.4M
Operating cash flow before change in receivables (GBP) — -29.6M 13M -23M -19.2M -24.4M -17.9M
Free cash flow (OCF - PPE - intangibles) (GBP) — -27.5M 9.8M -23.8M -17.9M -25.1M -19.6M
Income detail
Total comprehensive income (GBP) — 185M 450M -344M -175M -210M 67.2M
Comprehensive income to owners (GBP) — 185M 449M -342M -171M -206M 67.1M
Reported May 17, 2022 May 17, 2022 Apr 27, 2023 Aug 15, 2024 Aug 15, 2024 Apr 16, 2026 Apr 16, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

UK spinout investment surges to £1.56bn Bull 2 Bear 0 Other

Released : 22 Oct 2026 07:00:00

RNS Number : 8788Z

IP Group PLC

22 October 2026

FOR RELEASE ON 22 October 2026

UK spinout investment surges to £1.56bn

IP Group plc (LSE: IPO) ("IP Group"), which invests in breakthrough science and technology companies with the potential to create a better future for all, notes that investment in UK university spinouts reached £1.56bn in the first half of 2026, the second-highest half-year total in a decade.

According to a new report from Parkwalk, the Group's EIS fund management operation, and analytics firm Beauhurst, IP Group and Parkwalk remained the most active investors in UK spinouts, with 42 deals over the year to H1 2026. Over the past decade, IP Group and Parkwalk invested in 98 later-stage deals, more than twice as many as the next investor.

First-time equity investment fell from £148m in H1 2025 to £47.0m in H1 2026, a 68.3% drop. The number of first-time deals fell to 44, from a peak of 73 in H1 2021. Average deal size has more than doubled over the decade, from £3.57m to £7.24m. Together, these trends show capital concentrating in established spinouts while fewer new companies secure their first round. Full-year 2025 investment was £1.98bn, down 19.6% on 2024.

Greg Smith, CEO of IP Group, said: "British spinouts are now raising capital at a globally significant level, and international investors have taken notice. That is a real strength, and we should welcome it. But scale-up capital can and must be expanded at home to scale UK innovation. UK pension funds manage trillions of pounds, yet only a fraction reaches our most promising science-based businesses. By backing British science at the growth stage, more of the value created in our universities would stay here, for savers, for the economy and for the country. IP Group has made more later-stage investments in UK spinouts than anyone else over the past decade, and we will go further."

The full release follows:

UK SPINOUT INVESTMENT SURGES TO £1.56BN BUT FUNDING FOR NEW SPINOUTS SHRINKS BY TWO-THIRDS

·      UK spinouts raised £1.56bn in H1 2026, the second-highest half-year in a decade

·      Quantum and advanced computing lead, taking three of the four largest deals, which together raised £709m in the first half of the year

·      First-time investment fell 68.3% year-on-year to £47.0m, putting the pipeline of future spinouts under strain

·      Parkwalk calls on the Government to help stabilise EIS, ensuring the next generation of spinouts can access early-stage capital

·      Parkwalk and IP Group remain the UK's most active spinout investors, with 42 deals in the past year and 98 later-stage deals over the decade

Investment in UK university spinouts reached £1.56bn in the first half of 2026, the second-highest half-year total in a decade. Funding rose 38.2% compared with H2 2025 and came close to the £1.58bn record reached in H1 2021, according to a new report from Parkwalk, the UK's most active investor in university spinouts, and private company data provider Beauhurst.

The rebound was driven by a small number of large rounds. Four deals accounted for £709m, almost half of all capital raised. Three went to advanced computing companies: Quantum Motion, Oxford Quantum Circuits - both backed by Parkwalk - and Fractile. Oxford Quantum Circuits' £260m round was the largest of the period. Later-stage investment reached £760m, its highest half-year since 2021.

First-time equity investment fell from £148m in H1 2025 to £47.0m in H1 2026, a 68.3% drop. The number of first-time deals fell to 44, from a peak of 73 in H1 2021. Average deal size has more than doubled over the decade, from £3.57m to £7.24m. Together, these trends show capital concentrating in established spinouts while fewer new companies secure their first round. Full-year 2025 investment was £1.98bn, down 19.6% on 2024.

Moray Wright, CEO of Parkwalk, said: "British deeptech is attracting capital at a scale we have rarely seen, and that is something to celebrate. But these figures carry a clear warning. First-time investment has fallen, and the companies vital to the future of the UK economy are struggling to raise their first round. EIS is one of the most effective tools the UK has for backing early-stage science, and the Government should go further. Strengthening and expanding the scheme, with long-term certainty for investors, would unlock more private capital for new spinouts in every part of the country."

International capital remains a major strength of the UK ecosystem. Rounds with at least one international investor accounted for 86.1% of investment in H1 2026, the highest share this decade. That share is then 82.6% of all Later-stage investment since 2016. UK investors remain the backbone of deal activity - they took part in 2,545 deals since 2016, more than six times as many as US investors (408).

At the point of exit, however, value continues to flow overseas. International buyers accounted for 75% of spinout acquisitions in H1 2026, and 68.3% since 2016. US buyers have acquired 66 UK spinouts over the decade, more than UK buyers (57).

UK spinouts are diversifying. Digital and Technologies, which includes AI, quantum, and chips and processors, led sector investment at £1.44bn over the past year. Advanced Manufacturing followed at £1.17bn and Life Sciences at £1.16bn. All three align closely with the Government's Industrial Strategy priorities.

Investment remains heavily concentrated. Since 2016, nearly 80% has gone to the South East, East of England and London. The University of Oxford's spinouts have raised £5.39bn over that period, up on the University of Cambridge's £3.99bn. In the North, Manchester spinouts raised £195m over the decade and Liverpool's £19.6m. Parkwalk's Northern Universities Venture Fund, launched with Northern Gritstone in 2025 and now preparing for a second iteration, targets early-stage spinouts from Leeds, Liverpool, Manchester and Sheffield - aiming to support greater regional capital allocation.

Parkwalk and its parent IP Group were again the most active investors in UK spinouts, with 42 deals over the year to H1 2026, reinforcing their central role in supporting breakthrough innovation. Scottish Enterprise followed with 31 and the British Business Bank with 24. Over the past decade, Parkwalk and IP Group have invested in 98 later-stage deals, more than twice as many as the next investor.

Greg Smith, CEO of IP Group, said: "British spinouts are now raising capital at a globally significant level, and international investors have taken notice. That is a real strength, and we should welcome it. But scale-up capital can and must be expanded at home to scale UK innovation. UK pension funds manage trillions of pounds, yet only a fraction reaches our most promising science-based businesses. By backing British science at the growth stage, more of the value created in our universities would stay here, for savers, for the economy and for the country. IP Group has made more later-stage investments in UK spinouts than anyone else over the past decade, and we will go further."

UK spinout investment surges to £1.56bn Bull 2 Bear 0 Other

22 Oct 2026

IP Group plc (LSE: IPO) ("IP Group"), which invests in breakthrough science and technology companies with the potential to create a better future for all, notes that investment in UK university spinouts reached £1.56bn in the first half of 2026, the second-highest half-year total in a decade.

According to a new report from Parkwalk, the Group’s EIS fund management operation, and analytics firm Beauhurst, IP Group and Parkwalk remained the most active investors in UK spinouts, with 42 deals over the year to H1 2026. Over the past decade, IP Group and Parkwalk invested in 98 later-stage deals, more than twice as many as the next investor.

First-time equity investment fell from £148m in H1 2025 to £47.0m in H1 2026, a 68.3% drop. The number of first-time deals fell to 44, from a peak of 73 in H1 2021. Average deal size has more than doubled over the decade, from £3.57m to £7.24m. Together, these trends show capital concentrating in established spinouts while fewer new companies secure their first round. Full-year 2025 investment was £1.98bn, down 19.6% on 2024.

Greg Smith, CEO of IP Group, said: "British spinouts are now raising capital at a globally significant level, and international investors have taken notice. That is a real strength, and we should welcome it. But scale-up capital can and must be expanded at home to scale UK innovation. UK pension funds manage trillions of pounds, yet only a fraction reaches our most promising science-based businesses. By backing British science at the growth stage, more of the value created in our universities would stay here, for savers, for the economy and for the country. IP Group has made more later-stage investments in UK spinouts than anyone else over the past decade, and we will go further."

The full release follows:

UK SPINOUT INVESTMENT SURGES TO £1.56BN BUT FUNDING FOR NEW SPINOUTS SHRINKS BY TWO-THIRDS

  • UK spinouts raised £1.56bn in H1 2026, the second-highest half-year in a decade
  • Quantum and advanced computing lead, taking three of the four largest deals, which together raised £709m in the first half of the year
  • First-time investment fell 68.3% year-on-year to £47.0m, putting the pipeline of future spinouts under strain
  • Parkwalk calls on the Government to help stabilise EIS, ensuring the next generation of spinouts can access early-stage capital
  • Parkwalk and IP Group remain the UK's most active spinout investors, with 42 deals in the past year and 98 later-stage deals over the decade

Investment in UK university spinouts reached £1.56bn in the first half of 2026, the second-highest half-year total in a decade. Funding rose 38.2% compared with H2 2025 and came close to the £1.58bn record reached in H1 2021, according to a new report from Parkwalk, the UK’s most active investor in university spinouts, and private company data provider Beauhurst.

The rebound was driven by a small number of large rounds. Four deals accounted for £709m, almost half of all capital raised. Three went to advanced computing companies: Quantum Motion, Oxford Quantum Circuits – both backed by Parkwalk – and Fractile. Oxford Quantum Circuits' £260m round was the largest of the period. Later-stage investment reached £760m, its highest half-year since 2021.

First-time equity investment fell from £148m in H1 2025 to £47.0m in H1 2026, a 68.3% drop. The number of first-time deals fell to 44, from a peak of 73 in H1 2021. Average deal size has more than doubled over the decade, from £3.57m to £7.24m. Together, these trends show capital concentrating in established spinouts while fewer new companies secure their first round. Full-year 2025 investment was £1.98bn, down 19.6% on 2024.

Moray Wright, CEO of Parkwalk, said: "British deeptech is attracting capital at a scale we have rarely seen, and that is something to celebrate. But these figures carry a clear warning. First-time investment has fallen, and the companies vital to the future of the UK economy are struggling to raise their first round. EIS is one of the most effective tools the UK has for backing early-stage science, and the Government should go further. Strengthening and expanding the scheme, with long-term certainty for investors, would unlock more private capital for new spinouts in every part of the country."

International capital remains a major strength of the UK ecosystem. Rounds with at least one international investor accounted for 86.1% of investment in H1 2026, the highest share this decade. That share is then 82.6% of all Later-stage investment since 2016. UK investors remain the backbone of deal activity - they took part in 2,545 deals since 2016, more than six times as many as US investors (408).

At the point of exit, however, value continues to flow overseas. International buyers accounted for 75% of spinout acquisitions in H1 2026, and 68.3% since 2016. US buyers have acquired 66 UK spinouts over the decade, more than UK buyers (57).

UK spinouts are diversifying. Digital and Technologies, which includes AI, quantum, and chips and processors, led sector investment at £1.44bn over the past year. Advanced Manufacturing followed at £1.17bn and Life Sciences at £1.16bn. All three align closely with the Government's Industrial Strategy priorities.

Investment remains heavily concentrated. Since 2016, nearly 80% has gone to the South East, East of England and London. The University of Oxford's spinouts have raised £5.39bn over that period, up on the University of Cambridge's £3.99bn. In the North, Manchester spinouts raised £195m over the decade and Liverpool's £19.6m. Parkwalk's Northern Universities Venture Fund, launched with Northern Gritstone in 2025 and now preparing for a second iteration, targets early-stage spinouts from Leeds, Liverpool, Manchester and Sheffield – aiming to support greater regional capital allocation.

Parkwalk and its parent IP Group were again the most active investors in UK spinouts, with 42 deals over the year to H1 2026, reinforcing their central role in supporting breakthrough innovation. Scottish Enterprise followed with 31 and the British Business Bank with 24. Over the past decade, Parkwalk and IP Group have invested in 98 later-stage deals, more than twice as many as the next investor.

Greg Smith, CEO of IP Group, said: "British spinouts are now raising capital at a globally significant level, and international investors have taken notice. That is a real strength, and we should welcome it. But scale-up capital can and must be expanded at home to scale UK innovation. UK pension funds manage trillions of pounds, yet only a fraction reaches our most promising science-based businesses. By backing British science at the growth stage, more of the value created in our universities would stay here, for savers, for the economy and for the country. IP Group has made more later-stage investments in UK spinouts than anyone else over the past decade, and we will go further."

21 Oct 2026

Experimental research campaign will generate high-fidelity data to advance understanding of graphite under extreme impact conditions

  • Experiments will study graphite targets struck by steel projectiles at speeds above 3 km/s
  • Advancing understanding of impact performance under extreme conditions
  • Demonstrates the wider application of First Light’s specialist facilities and expertise across defence and advanced materials research

First Light Fusion has been selected to deliver an experimental campaign for the UK Defence Science and Technology Laboratory (Dstl) to investigate the behaviour of graphite under high-velocity impact conditions.

First Light’s integrated gas gun and pulsed power platforms can reproduce extreme temperatures and pressures enabling customers to test materials and components under conditions relevant across aerospace, defence and space.

Combined with advanced diagnostics, simulation and proprietary amplification technology, these capabilities support high-quality experimental data.

The campaign will provide Dstl with valuable experimental data to improve understanding of material performance under extreme loading conditions, supporting ongoing research into material strength transitions, crater formation and energy dissipation mechanisms.

First Light Fusion will reproduce a landmark hypervelocity impact experiment conducted by Hébert et al. (2017), which examined the impact of steel projectiles into porous graphite. Replicating the study will enable direct comparison with published results, validating experimental methods and measurement accuracy while investigating an observed change in material behaviour at impact velocities above approximately 3 km/s.

The targets supplied by Dstl will be configured for post-shot recovery and detailed inspection, providing additional insight into damage mechanisms and impact effects.

Paul Holligan, VP, Commercial and Partnerships at First Light Fusion said:

"This programme demonstrates the growing demand for First Light Fusion's capabilities beyond fusion energy. Our expertise in hypervelocity impact physics and advanced diagnostics enables us to provide customers with unique experimental services, generating the high-quality data needed to understand material behaviour in some of the most extreme environments".

Dstl stated:

_"_This programme will generate valuable experimental evidence to deepen our understanding of how materials behave under hypervelocity impact. First Light Fusion’s specialist facilities and expertise will enable us to examine these effects across a carefully controlled range of conditions, supporting the development and validation of improved material models for defence applications”.

The project represents another example of how First Light Fusion's facilities, amplification technology and simulation capabilities, developed in support of its fusion mission, can support government and commercial organisations working on complex challenges in defence, aerospace and advanced materials research.

About First Light Fusion

First Light Fusion is an Oxford-based company making commercial fusion possible with FLARE, its two-stage fusion fuel system, while applying its unique capabilities to solve the hardest problems in space, defence and beyond.

Founded in 2011, First Light has spent 15 years building deep expertise across fusion physics, simulation, target design, precision manufacturing, and experimental validation. Its world-class facilities, including pulsed-power machines and the UK's largest two-stage gas gun, serve as multi-use platforms driving both fusion development and broader high-energy-density physics research under extreme conditions.

In September 2025, First Light published its landmark research paper, ‘FLARE – A Bold Strategy to Unlock Fusion Power’, outlining the world’s first commercially viable, reactor-compatible pathway to high-gain inertial fusion, offering a simpler, more viable route to abundant clean energy.

Prompts

IP Group PLC (ticker IPO), listed in United Kingdom.

ETFs Holding IP Group PLC

ETF Weight in ETF Shares Market value As of
AVDS 0.03% 107,266 $ 106.33K Nov 16, 2026
AVDE 0.01% 1,872,535 $ 1.856M Nov 16, 2026
AVSD 0.01% 48,167 $ 47.747K Nov 16, 2026